Low-Dose Naltrexone: What's New
LDN
•
54m
Join us to discover the latest and greatest in naltrexone compounding with PCCA Clinical Compounding Pharmacist Sebastian Denison, RPh. He'll share updated information you need to know, plus uncover new compounding options to grow your practice.
You'll learn:
New and updated LDN dosing considerations
How LDN is changing the world of dermatology
LDN benefits for cancer patients — and how it can be the starting point for your entry into the oncology practice setting
Up Next in LDN
-
Compounding for Chronic Disease and C...
Download Handout: https://bit.ly/478vIRZ
Run Time: 34 minutesPCCA Clinical Compounding Pharmacist Nat Jones reveals nutritional supplements and compounds for the health conditions such as insulin resistance, oxidative stress, and increasing mitochondrial energy production.
-
Low-Dose Naltrexone (LDN): Updates Th...
40min
Handout: https://bit.ly/3W3OeYr
In this presentation Sebastian Denison, RPh, FAARM (cand.), talks about updates that might be important in regards to low-dose naltrexone.
-
Marketing LDN Formulas
38 Min
Handout: https://bit.ly/3PHd10V
In this presentation Sebastian Denison, RPh, FAARM (cand.), talks about how to market LDN formulas.
